Acinetobacter baumannii Resistance: A Real Challenge for Clinicians
Published 2020 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Acinetobacter baumannii Resistance: A Real Challenge for Clinicians
Authors
Keywords
-
Journal
Antibiotics-Basel
Volume 9, Issue 4, Pages 205
Publisher
MDPI AG
Online
2020-04-24
DOI
10.3390/antibiotics9040205
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- 2-Hydroxylation of Acinetobacter baumannii Lipid A Contributes to Virulence
- (2019) Toby L. Bartholomew et al. INFECTION AND IMMUNITY
- Phage Therapy as a Promising New Treatment for Lung Infection Caused by Carbapenem-Resistant Acinetobacter baumannii in Mice
- (2018) Yunfen Hua et al. Frontiers in Microbiology
- Molecular characterization of plasmid-encoded blaTEM, blaSHV and blaCTX-M among extended spectrum β-lactamases [ESBLs] producing Acinetobacter baumannii
- (2018) ASG Smiline et al. BRITISH JOURNAL OF BIOMEDICAL SCIENCE
- Prevalence and Mechanisms of Carbapenem Resistance Among Acinetobacter baumannii Clinical Isolates in Egypt
- (2018) Abdalbagi Basheer Benmahmod et al. Microbial Drug Resistance
- TimeTree: A Resource for Timelines, Timetrees, and Divergence Times
- (2017) Sudhir Kumar et al. MOLECULAR BIOLOGY AND EVOLUTION
- Uncovering the mechanisms of Acinetobacter baumannii virulence
- (2017) Christian M. Harding et al. NATURE REVIEWS MICROBIOLOGY
- Biology of Acinetobacter baumannii: Pathogenesis, Antibiotic Resistance Mechanisms, and Prospective Treatment Options
- (2017) Chang-Ro Lee et al. Frontiers in Cellular and Infection Microbiology
- Global Assessment of the Activity of Tigecycline against Multidrug-Resistant Gram-Negative Pathogens between 2004 and 2014 as Part of the Tigecycline Evaluation and Surveillance Trial
- (2017) Anna Giammanco et al. mSphere
- Clinical Antibiotic-resistant Acinetobacter baumannii Strains with Higher Susceptibility to Environmental Phages than Antibiotic-sensitive Strains
- (2017) Li-Kuang Chen et al. Scientific Reports
- In VitroBactericidal Activity of Trimethoprim-Sulfamethoxazole Alone and in Combination with Colistin against Carbapenem-Resistant Acinetobacter baumannii Clinical Isolates
- (2016) Martha Nepka et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- In VitroActivity of Fusidic Acid-Containing Combinations against Carbapenem-Resistant Acinetobacter baumannii Clinical Strains
- (2016) Sarah L. Bowler et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- In VitroSynergistic Activity of Antimicrobial Agents in Combination against Clinical Isolates of Colistin-Resistant Acinetobacter baumannii
- (2016) Seongman Bae et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- In VivoApplication of Bacteriophage as a Potential Therapeutic Agent To Control OXA-66-Like Carbapenemase-Producing Acinetobacter baumannii Strains Belonging to Sequence Type 357
- (2016) Jongsoo Jeon et al. APPLIED AND ENVIRONMENTAL MICROBIOLOGY
- Clinical and Pathophysiological Overview of Acinetobacter Infections: a Century of Challenges
- (2016) Darren Wong et al. CLINICAL MICROBIOLOGY REVIEWS
- Colistin enhances therapeutic efficacy of daptomycin or teicoplanin in a murine model of multiresistant Acinetobacter baumannii sepsis
- (2016) Oscar Cirioni et al. DIAGNOSTIC MICROBIOLOGY AND INFECTIOUS DISEASE
- Synergistic killing by meropenem and colistin combination of carbapenem-resistant Acinetobacter baumannii isolates from Chinese patients in an in vitro pharmacokinetic/pharmacodynamic model
- (2016) Xiaofen Liu et al. INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS
- Regional differences and trends in antimicrobial susceptibility of Acinetobacter baumannii
- (2016) Sibylle H. Lob et al. INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS
- Polymyxin B in combination with doripenem against heteroresistant Acinetobacter baumannii : pharmacodynamics of new dosing strategies
- (2016) Gauri G. Rao et al. JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY
- High rate of colistin dependence inAcinetobacter baumannii
- (2016) Yoon-Kyoung Hong et al. JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY
- Activity of Colistin in Combination with Meropenem, Tigecycline, Fosfomycin, Fusidic Acid, Rifampin or Sulbactam against Extensively Drug-Resistant Acinetobacter baumannii in a Murine Thigh-Infection Model
- (2016) Bing Fan et al. PLoS One
- Colistin-Resistant Acinetobacter baumannii: Beyond Carbapenem Resistance
- (2015) Zubair A. Qureshi et al. CLINICAL INFECTIOUS DISEASES
- Structural Basis for Carbapenem-Hydrolyzing Mechanisms of Carbapenemases Conferring Antibiotic Resistance
- (2015) Jeong Jeon et al. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
- Risk factors for nephrotoxicity onset associated with polymyxin B therapy
- (2015) Y. Dubrovskaya et al. JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY
- Acinetobacter baumannii: Evolution of Antimicrobial Resistance—Treatment Options
- (2015) Gerald Murray et al. SEMINARS IN RESPIRATORY AND CRITICAL CARE MEDICINE
- Reinforcing Lipid A Acylation on the Cell Surface of Acinetobacter baumannii Promotes Cationic Antimicrobial Peptide Resistance and Desiccation Survival
- (2015) Joseph M. Boll et al. mBio
- Antibacterial Mechanisms of Polymyxin and Bacterial Resistance
- (2015) Zhiliang Yu et al. Biomed Research International
- Clinical Outcomes of Hospital-Acquired Infection with Acinetobacter nosocomialis and Acinetobacter pittii
- (2014) Sarunyou Chusri et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Antibacterial properties of Acinetobacter baumanniiphage Abp1 endolysin (PlyAB1)
- (2014) Guangtao Huang et al. BMC INFECTIOUS DISEASES
- Treatment Options for Carbapenem-Resistant and Extensively Drug-Resistant Acinetobacter baumannii Infections
- (2014) J. Alexander Viehman et al. DRUGS
- Comparison of colistin–carbapenem, colistin–sulbactam, and colistin plus other antibacterial agents for the treatment of extremely drug-resistant Acinetobacter baumannii bloodstream infections
- (2014) A. Batirel et al. EUROPEAN JOURNAL OF CLINICAL MICROBIOLOGY & INFECTIOUS DISEASES
- The Genomic Diversification of the Whole Acinetobacter Genus: Origins, Mechanisms, and Consequences
- (2014) Marie Touchon et al. Genome Biology and Evolution
- Multistate Point-Prevalence Survey of Health Care–Associated Infections
- (2014) Shelley S. Magill et al. NEW ENGLAND JOURNAL OF MEDICINE
- Engineered Endolysin-Based "Artilysins" To Combat Multidrug-Resistant Gram-Negative Pathogens
- (2014) Y. Briers et al. mBio
- Antimicrobial resistance inAcinetobacter baumannii: From bench to bedside
- (2014) Ming-Feng Lin World Journal of Clinical Cases
- The Biology of the PmrA/PmrB Two-Component System: The Major Regulator of Lipopolysaccharide Modifications
- (2013) H. Deborah Chen et al. Annual Review of Microbiology
- In VitroPharmacodynamics of Polymyxin B and Tigecycline Alone and in Combination against Carbapenem-Resistant Acinetobacter baumannii
- (2013) Mao Hagihara et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Contribution of Efflux Pumps, Porins, and β-Lactamases to Multidrug Resistance in Clinical Isolates of Acinetobacter baumannii
- (2013) C. Rumbo et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- OXA-235, a Novel Class D β-Lactamase Involved in Resistance to Carbapenems in Acinetobacter baumannii
- (2013) Paul G. Higgins et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Virulence-related traits of epidemic Acinetobacter baumannii strains belonging to the international clonal lineages I-III and to the emerging genotypes ST25 and ST78
- (2013) Maria Giannouli et al. BMC INFECTIOUS DISEASES
- Population Pharmacokinetics of Intravenous Polymyxin B in Critically Ill Patients: Implications for Selection of Dosage Regimens
- (2013) Ana M. Sandri et al. CLINICAL INFECTIOUS DISEASES
- Seven Ways to Preserve the Miracle of Antibiotics
- (2013) J. G. Bartlett et al. CLINICAL INFECTIOUS DISEASES
- Carbapenem resistance and mortality in patients with Acinetobacter baumannii infection: systematic review and meta-analysis
- (2013) E.V. Lemos et al. CLINICAL MICROBIOLOGY AND INFECTION
- Pharmacology of polymyxins: new insights into an ‘old’ class of antibiotics
- (2013) Tony Velkov et al. Future Microbiology
- TEM-1 -lactamase as a source of resistance to sulbactam in clinical strains of Acinetobacter baumannii
- (2013) L. Krizova et al. JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY
- Real-Time Sequencing To Decipher the Molecular Mechanism of Resistance of a Clinical Pan-Drug-Resistant Acinetobacter baumannii Isolate from Marseille, France
- (2012) Jean-Marc Rolain et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Rapid Killing of Acinetobacter baumannii by Polymyxins Is Mediated by a Hydroxyl Radical Death Pathway
- (2012) Timothy R. Sampson et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Colistin vs. the combination of colistin and rifampicin for the treatment of carbapenem-resistant Acinetobacter baumannii ventilator-associated pneumonia
- (2012) H. AYDEMIR et al. EPIDEMIOLOGY AND INFECTION
- Colistin: an update on the antibiotic of the 21st century
- (2012) Silpak Biswas et al. Expert Review of Anti-Infective Therapy
- Bacteriophage endolysins as novel antimicrobials
- (2012) Mathias Schmelcher et al. Future Microbiology
- Colistin resistance of Acinetobacter baumannii: clinical reports, mechanisms and antimicrobial strategies
- (2012) Y. Cai et al. JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY
- Risk Factors for Mortality in Patients with Carbapenem-Resistant Acinetobacter baumannii Bacteremia: Impact of Appropriate Antimicrobial Therapy
- (2012) Youn Jeong Kim et al. JOURNAL OF KOREAN MEDICAL SCIENCE
- Role of ISAba1 and ISAba125 in governing the expression of blaADC in clinically relevant Acinetobacter baumannii strains resistant to cephalosporins
- (2012) B. S. Lopes et al. JOURNAL OF MEDICAL MICROBIOLOGY
- Genetic Mechanisms of Antimicrobial Resistance of Acinetobacter Baumannii
- (2011) John S Esterly et al. ANNALS OF PHARMACOTHERAPY
- Extended-Spectrum AmpC Cephalosporinase in Acinetobacter baumannii: ADC-56 Confers Resistance to Cefepime
- (2011) Guo-Bao Tian et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- ThepmrCABOperon Mediates Polymyxin Resistance inAcinetobacter baumanniiATCC 17978 and Clinical Isolates through Phosphoethanolamine Modification of Lipid A
- (2011) Luis A. Arroyo et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Phosphoethanolamine Modification of Lipid A in Colistin-Resistant Variants of Acinetobacter baumannii Mediated by the pmrAB Two-Component Regulatory System
- (2011) Alejandro Beceiro et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Activities of colistin- and minocycline-based combinations against extensive drug resistant Acinetobacter baumannii isolates from intensive care unit patients
- (2011) Wang Liang et al. BMC INFECTIOUS DISEASES
- Comparative in vitro antimicrobial susceptibilities and synergistic activities of antimicrobial combinations against carbapenem-resistant Acinetobacter species: Acinetobacter baumannii versus Acinetobacter genospecies 3 and 13TU
- (2011) Wang-Huei Sheng et al. DIAGNOSTIC MICROBIOLOGY AND INFECTIOUS DISEASE
- Molecular epidemiology and mechanisms of rifampicin resistance in Acinetobacter baumannii isolates from Italy
- (2011) Maria Giannouli et al. INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS
- In vitro activity of teicoplanin combined with colistin versus multidrug-resistant strains of Acinetobacter baumannii
- (2011) D. W. Wareham et al. JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY
- Emergence of NDM-1-producing Acinetobacter baumannii in China
- (2011) Y. Chen et al. JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY
- In vitro time-kill studies of antimicrobial agents against blood isolates of imipenem-resistant Acinetobacter baumannii, including colistin- or tigecycline-resistant isolates
- (2011) Kyong Ran Peck et al. JOURNAL OF MEDICAL MICROBIOLOGY
- Deciphering the Multifactorial Nature of Acinetobacter baumannii Pathogenicity
- (2011) Luísa C. S. Antunes et al. PLoS One
- Efficacy of Rifampin and Its Combinations with Imipenem, Sulbactam, and Colistin in Experimental Models of Infection Caused by Imipenem-Resistant Acinetobacter baumannii
- (2010) M. E. Pachon-Ibanez et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Overexpression of Resistance-Nodulation-Cell Division Pump AdeFGH Confers Multidrug Resistance in Acinetobacter baumannii
- (2010) S. Coyne et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Efflux-Mediated Antibiotic Resistance inAcinetobacterspp.
- (2010) Sébastien Coyne et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Colistin Resistance in Acinetobacter baumannii Is Mediated by Complete Loss of Lipopolysaccharide Production
- (2010) J. H. Moffatt et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Postantibiotic Effects of Tigecycline, Colistin Sulfate, and Levofloxacin Alone or Tigecycline-Colistin Sulfate and Tigecycline-Levofloxacin Combinations against Acinetobacter baumannii
- (2010) Berna Özbek et al. CHEMOTHERAPY
- The 10 × ‘20 Initiative: Pursuing a Global Commitment to Develop 10 New Antibacterial Drugs by 2020
- (2010) CLINICAL INFECTIOUS DISEASES
- Influence of Genospecies of Acinetobacter baumannii Complex on Clinical Outcomes of Patients with Acinetobacter Bacteremia
- (2010) Y.-C. Chuang et al. CLINICAL INFECTIOUS DISEASES
- The K1 Capsular Polysaccharide of Acinetobacter baumannii Strain 307-0294 Is a Major Virulence Factor
- (2010) T. A. Russo et al. INFECTION AND IMMUNITY
- Inactivation of Phospholipase D Diminishes Acinetobacter baumannii Pathogenesis
- (2010) A. C. Jacobs et al. INFECTION AND IMMUNITY
- Identification and Characterization of a Glycosyltransferase Involved in Acinetobacter baumannii Lipopolysaccharide Core Biosynthesis
- (2010) N. R. Luke et al. INFECTION AND IMMUNITY
- Clinical Outcomes of Carbapenem-Resistant Acinetobacter baumannii Bloodstream Infections: Study of a 2-State Monoclonal Outbreak
- (2010) L. Silvia Munoz-Price et al. INFECTION CONTROL AND HOSPITAL EPIDEMIOLOGY
- Multidrug-resistant Acinetobacter baumannii: mechanisms of virulence and resistance
- (2010) Nicola C. Gordon et al. INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS
- A multicenter study of risk factors and outcome of hospitalized patients with infections due to carbapenem-resistant Acinetobacter baumannii
- (2010) Wang-Huei Sheng et al. INTERNATIONAL JOURNAL OF INFECTIOUS DISEASES
- Antimicrobial activity of a novel aminoglycoside, ACHN-490, against Acinetobacter baumannii and Pseudomonas aeruginosa from New York City
- (2010) D. Landman et al. JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY
- AdeABC-mediated efflux and tigecycline MICs for epidemic clones of Acinetobacter baumannii
- (2010) M. Hornsey et al. JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY
- Aminoglycoside Resistance and Susceptibility Testing Errors in Acinetobacter baumannii-calcoaceticus Complex
- (2010) K. S. Akers et al. JOURNAL OF CLINICAL MICROBIOLOGY
- Dissection of Host Cell Signal Transduction during Acinetobacter baumannii – Triggered Inflammatory Response
- (2010) Catalina March et al. PLoS One
- Molecular Mechanisms of Ethanol-Induced Pathogenesis Revealed by RNA-Sequencing
- (2010) Laura Camarena et al. PLoS Pathogens
- Overexpression of the Naturally Occurring blaOXA-51 Gene in Acinetobacter baumannii Mediated by Novel Insertion Sequence ISAba9
- (2009) S. Figueiredo et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Tetracycline Susceptibility Testing and Resistance Genes in Isolates of Acinetobacter baumannii-Acinetobacter calcoaceticus Complex from a U.S. Military Hospital
- (2009) K. S. Akers et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- In Vitro Activity of Colistin (Polymyxin E) against 3,480 Isolates of Gram-Negative Bacilli Obtained from Patients in Canadian Hospitals in the CANWARD Study, 2007-2008
- (2009) A. Walkty et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Genetic basis of resistance to aminoglycosides in Acinetobacter spp. and spread of armA in Acinetobacter baumannii sequence group 1 in Korean hospitals
- (2009) Yoo Jin Cho et al. DIAGNOSTIC MICROBIOLOGY AND INFECTIOUS DISEASE
- Serum resistance ofAcinetobacter baumanniithrough the binding of factor H to outer membrane proteins
- (2009) Sang Woo Kim et al. FEMS MICROBIOLOGY LETTERS
- Proteome analysis of outer membrane vesicles from a clinicalAcinetobacter baumanniiisolate
- (2009) Sang-Oh Kwon et al. FEMS MICROBIOLOGY LETTERS
- The Acinetobacter baumannii 19606 OmpA Protein Plays a Role in Biofilm Formation on Abiotic Surfaces and in the Interaction of This Pathogen with Eukaryotic Cells
- (2009) J. A. Gaddy et al. INFECTION AND IMMUNITY
- Tigecycline use in two cases with multidrug-resistant Acinetobacter baumannii meningitis
- (2009) E. Ediz Tutuncu et al. INTERNATIONAL JOURNAL OF INFECTIOUS DISEASES
- The pgaABCD Locus of Acinetobacter baumannii Encodes the Production of Poly- -1-6-N-Acetylglucosamine, Which Is Critical for Biofilm Formation
- (2009) A. H. K. Choi et al. JOURNAL OF BACTERIOLOGY
- Acinetobacter: an old friend, but a new enemy
- (2009) K.J. Towner JOURNAL OF HOSPITAL INFECTION
- In vitro activity of tigecycline in combination with various antimicrobials against multidrug resistant Acinetobacter baumannii
- (2009) Luigi Principe et al. Annals of Clinical Microbiology and Antimicrobials
- Genetic Basis of Multidrug Resistance in Acinetobacter baumannii Clinical Isolates at a Tertiary Medical Center in Pennsylvania
- (2008) J. M. Adams-Haduch et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Acinetobacter baumannii invades epithelial cells and outer membrane protein A mediates interactions with epithelial cells
- (2008) Chul Hee Choi et al. BMC MICROBIOLOGY
- Bad Bugs, No Drugs: No ESKAPE! An Update from the Infectious Diseases Society of America
- (2008) Helen W. Boucher et al. CLINICAL INFECTIOUS DISEASES
- Acinetobacter baumannii: Emergence of a Successful Pathogen
- (2008) A. Y. Peleg et al. CLINICAL MICROBIOLOGY REVIEWS
- Global gene expression patterns and induction of innate immune response in human laryngeal epithelial cells in response toAcinetobacter baumanniiouter membrane protein A
- (2008) Soon Ae Kim et al. FEMS IMMUNOLOGY AND MEDICAL MICROBIOLOGY
- Nuclear translocation and DNAse I-like enzymatic activity ofAcinetobacter baumanniiouter membrane protein A
- (2008) Chul Hee Choi et al. FEMS MICROBIOLOGY LETTERS
- Comparative Analysis of Acinetobacters: Three Genomes for Three Lifestyles
- (2008) David Vallenet et al. PLoS One
- Capacity of multidrug-resistant clinical isolates of Acinetobacter baumannii to form biofilm and adhere to epithelial cell surfaces
- (2007) H.-W. Lee et al. CLINICAL MICROBIOLOGY AND INFECTION
Find the ideal target journal for your manuscript
Explore over 38,000 international journals covering a vast array of academic fields.
SearchAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started